Mohammad Ma'koseh, Alaa Abufara, Dana Albaghdadi, Ruba Ghalayni, Sarah Abdel-Razeq, Eman Alzughali, Fadwa Abdel Rahman, Yazan Alhalaseh, Khalid Halahleh, Hikmat Abdel-Razeq
Background: A majority of patients included in risk assessment models (RAMs) developed to predict venous thromboembolic events (VTE) in lymphoma were non-Hodgkin lymphoma. Our study aims to evaluate the incidence and predictors of VTE, utilizing different RAMs, in patients with classic Hodgkin lymphoma (cHL) treated with adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD). Methods : Adult patients with cHL, treated and followed at our center, were included. Correlations between different variables, Khorana score, and thrombosis in lymphoma (ThroLy) RAMs with VTE were examined using Fisher's exact test and logistic regression analysis...
January 12, 2024: Journal of Clinical Medicine